Forum

asn99
@asn9
Trusted Member
Joined: Oct 30, 2016
Last seen: Oct 10, 2022
Topics: 3 / Replies: 50
Reply
RE: Risk management and Labels

I would agree with Dr. Simon that it makes sense why labeling would not be considered a strong way to mitigate risk. While warning and instruction lab...

8 years ago
Reply
RE: Risk analysis in real company

Thank you very much for the interesting question. I would agree with Tarek that determining the risk associated with a project is a team effort. Each ...

8 years ago
Reply
RE: Making up tests for design verification and validation

Hi Roberto, After doing some research, I was able to find that the FDA does not demand specific tests, but establishes guidelines for developing des...

8 years ago
Reply
RE: Minutes for meetings

Hi Roberto, Thank you very much for your question. I would agree with Dr. Simon that meeting minutes are extremely important. I have been in meeting...

8 years ago
Reply
RE: Design Transfer and Challenges

Hi All, I wanted to elaborate a little on a point that was made about the difficulty of the purchasing department not not having enough time to iden...

8 years ago
Reply
RE: Consequences Of Insufficient Design Controls

Hi Lamiaa, Thank you for your questions and the examples provided by the others. I believe that one main issue that would occur is that the projec...

8 years ago
Reply
RE: Important Part of DDP

Thank you very much for your interesting question. I would agree with Tarek that it is difficult to choose which area of the DDP is most important, bu...

8 years ago
Reply
RE: Discussion Topic: Supplemental on DHF and DMR

Yes, Design Controls would be needed for a medical device in the EU. While there would be no DHF needed in the EU, most of the parts of design control...

8 years ago
Page 4 / 4